Skip to content
lifestyle.houstonnewstoday.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Sanofi Winthrop Industrie
Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
June 8, 2026
Press Release: Sanofi launches 2026 global employee stock purchase plan
June 4, 2026
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
May 28, 2026
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
May 21, 2026
Press Release: Annual General Meeting of April 29, 2026 – Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
April 29, 2026
Press Release: Sanofi successfully prices 2.3 billion of bond issue
April 29, 2026
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
April 29, 2026
Press Release: Q1 2026: double-digit sales and business EPS growth
April 29, 2026
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
April 29, 2026
Press Release: Sanofi’s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
April 28, 2026
1
2
3
4
Next Page
→